Bettina Hansen, MSc, PhD

Follow Dr. Hansen:

https://orcid.org/0000-0001-8307-3341

Dr. Bettina Hansen studied statistics and mathematics at the Institute of Mathematical Statistics at the University of Copenhagen in Denmark. Next, she completed her PhD entitled 'Statistical models of treatment effects in chronic hepatitis B and C' in the Department of Gastroenterology and Hepatology at Erasmus University Medical Center (Erasmus MC) in the Netherlands.

Presently, she is a Senior Biostatistician in the Toronto Centre for Liver Disease at Toronto General Hospital and an Associate Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. She also holds an academic appointment at Erasmus MC.

Together with the clinical research team, Dr. Hansen leads high-quality clinical research projects related to liver disease. The overall goal of her research program is to develop tools that can accurately identify patients who are at highest risk of experiencing disease progression or most likely to respond to treatment. To achieve this goal, she is developing individualized prediction models and dynamic scoring methods that can be applied in the daily medical practice.

In collaboration with national and international researchers, she has coordinated several global studies on antiviral treatment for viral hepatitis including HBV 99-01, VIRID, PARC, ARES, PEGON, GIANT-B, PAS, PEGON, the HCV Cohort Study and the Toronto Viral Hepatitis Care Network (VIRCAN). She also led the Global Primary Biliary Cholangitis (PBC) Group and the International Primary Sclerosis Cholangitis (PSC) study group, and initiated data registries for rare liver diseases in children (ie, NAPPED, GALA - projects). In Canada, she initiated the Canadian Network for Autoimmune Studies (CaNAL) which currenlty focuses on PBC and autoimmune hepatitis (AIH).
 

Viruses. 2019 Jul 26;11(8):
Hees SV, Chi H, Hansen B, Bourgeois S, Vlierberghe HV, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T
Sci Rep. 2019 Jul 23;9(1):10677
Sideras K, de Man RA, Harrington SM, Polak WG, Zhou G, Schutz HM, Pedroza-Gonzalez A, Biermann K, Mancham S, Hansen BE, Bart Takkenberg R, van Vuuren AJ, Pan Q, Ijzermans JNM, Sleijfer S, Sprengers D, Dong H, Kwekkeboom J, Bruno MJ
Hepatology. 2019 Jul 15;:
Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K
J Hepatol. 2019 Jul 03;:
Goet JC, Floreani A, Verhelst X, Cazzagon N, Perini L, Lammers WJ, de Vries AC, van der Meer AJ, van Buuren HR, Hansen BE
J Viral Hepat. 2019 May 28;:
van Campenhout MJH, Rijckborst V, Brouwer WP, van Oord GW, Ferenci P, Tabak F, Akdogan M, Pinarbasi B, Simon K, de Knegt RJ, Boonstra A, Janssen HLA, Hansen BE
J Hepatol. 2019 Apr 10;:
Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ
Lancet Gastroenterol Hepatol. 2019 Apr 08;:
Sonneveld MJ, Brouwer WP, Chan HL, Piratvisuth T, Jia JD, Zeuzem S, Liaw YF, Hansen BE, Choi H, Wat C, Pavlovic V, Gaggar A, Xie Q, Buti M, de Knegt RJ, Janssen HLA
Liver Int. 2019 Mar 25;:
Liem KS, Yim C, Ying TD, Zanjir W, Fung S, Wong DK, Shah H, Feld JJ, Hansen BE, Janssen HLA
J Viral Hepat. 2019 Feb 23;:
Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen HLA, Vanwolleghem T
Am J Gastroenterol. 2019 Mar;114(3):511-518
de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E

Pages


Associate Professor, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
Senior Biostatistician, Toronto Centre for Liver Disease, Toronto General Hospital
Senior Biostatistician and Associate Professor, Dept of Gastroenterology and Hepatology, Erasmus MC, the Netherlands